William studied the genomic landscape of metastatic endometrial cancers and CYCLOPs genes as therapeutic targets in breast cancers as a graduate student in the Beroukhim Lab. He graduated from his MD-PhD studies in 2017, completed his residency in Medicine at the Brigham and Women’s Hospital in 2019, and is now a fellow in Medical Oncology at the Dana-Farber Cancer Institute.